OUR PRODUCT AREAS
NOVEL SOLUTIONS FOR LIQUID BIOPSY AND EXOSOME CAPTURE
The Sevident technology platform has already been used to develop a number of diagnostic prototypes and solutions in oncology and infectious disease. Most recently, Sevident has taken advantage of our highly sensitive technology platform to develop a new suite of tools for analyzing cell-free DNA (cfDNA) for non-invasive cancer screening via liquid biopsy through an exosome capture tool.
Through both independent research and industry and academic collaborations, Sevident is actively involved a number of other projects for diagnostic development including HIV, MRSA, and agricultural pathogens. With funding from an NIH SBIR Grant, Sevident, in collaboration with Lawrence Livermore National Laboratories, is also currently developing a multi-serotype point-of-care diagnostic for Dengue Fever.
HIGHLY CUSTOMIZABLE CELLULAR AND MOLECULAR CAPTURE
Sevident NETs are fully customizable to outperform existing technologies and improve the sensitivities of pre-existing assays to femto-molar levels, and our compatibility with raw samples often enables a 30-45 minute sample-to-answer time. NETs are a cost-effective solution to increase sensitivity and marker recovery from a variety of sample types.
Sevident technology has been succesfully used to capture and analyze a wide range of molecular targets including proteins, lipids, nucleic acids, vesicles, and even whole bacterial, fungal, and human cells, often from the most troublesome of solutions and sample types.
SPECIALTY TOOLS FOR STUDYING THE HUMAN MICROBIOME
Our bodies are home to an estimated 100 trillion microbes, the vast majority of which are still poorly understood. As an emerging field with enormous potential, microbiome-based diagnostics and therapeutics for cancer, gastrointestinal disorders, and autoimmune diseases face critical technical hurdles. Current microbiome kits take hours of prep time and are plagued with human DNA contamination, wasting millions of research dollars.
Sevident has developed a suite of human microbiome capture tools that benefit from significantly reduced human contamination, increased nucleic acid yield, and a quick, 30-45 minute sample prep time. Our unique microbiome kits allow for extraction and analysis of bacterial, fungal, viral, and human genomic data.